{{Rsnum
|rsid=2305949
|Gene=KDR
|Chromosome=4
|position=55114289
|Orientation=plus
|GMAF=0.1474
|Gene_s=KDR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.0 | 32.4 | 3.6
| HCB | 61.1 | 35.9 | 3.1
| JPT | 71.4 | 25.9 | 2.7
| YRI | 81.2 | 18.8 | 0.0
| ASW | 90.9 | 9.1 | 0.0
| CHB | 61.1 | 35.9 | 3.1
| CHD | 58.7 | 36.5 | 4.8
| GIH | 71.3 | 26.7 | 2.0
| LWK | 84.3 | 14.8 | 0.9
| MEX | 84.5 | 15.5 | 0.0
| MKK | 64.5 | 34.2 | 1.3
| TSI | 53.0 | 42.0 | 5.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23566851
|Title=Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations
}}

{{PMID Auto
|PMID=20019880
|Title=Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}